In this presentation, Tim Le Fevre discusses applications and advantages of hPSC-derived immune cells for cell therapy research. He demonstrates how to efficiently differentiate hPSCs into functional immune cells without the need for feeder cells or serum-containing culture media. Tim Le Fevre is a scientist in the hematopoietic research group at STEMCELL Technologies.

This presentation and the following Q&A were moderated by Dr. Glyn Stacey from EuroStemCell and Dr. Adam Hirst from STEMCELL Technologies. It was part of the workshop “From hPSCs to Immune Cells”, hosted together with the London Stem Cell Network. During the event, scientists and experts presented on advancements in hPSC culture, the generation of immune cells, and the demands of cell therapy research. Explore the full series here >